Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLG | P54098 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.41 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.40 |
| ▸ | POLA1 | P09884 | 2/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22508617 | 0.84 | POLG (0.58) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL20879410 | 0.81 | POLG (0.59) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL18840676 | 0.81 | POLG (0.59) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL20018627 | 0.81 | PDE3A (0.46) | POLGPOLBFGFR1POLA1 | |
| SCHEMBL22475057 | 0.77 | POLG (0.54) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL20417774 | 0.76 | POLG (0.53) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL20879524 | 0.76 | POLG (0.55) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL19934321 | 0.75 | POLG (0.52) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL22474997 | 0.75 | POLG (0.58) | POLGPOLBP2RY2P2RY6P2RY4 | |
| SCHEMBL23171242 | 0.74 | POLG (0.60) | POLGPOLBP2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020041051-A1 | GEMCITABINE PRODRUGS | CURE BIOPHARMA INC. (US) | 2020-02-27 | — | — | WO | disclosed |